undamentalytics Newsletter
Sign in

Longeveron Inc. balance sheet

At the end of fiscal 2025, Longeveron Inc. had total assets of $10.3m, total liabilities of $4.6m and shareholders' equity of $5.7m. It held $4.7m in cash against $0 of debt: net cash of $4.7m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents12611519510
Receivables—000000
Total current assets23520620511
Total assets9432712261015
Accounts payable2121001
Deferred revenue (current)—011000
Total current liabilities4354344
Short-term debt0——————
Long-term debt0——————
Total debt332—000
Total liabilities7575455
Shareholders' equity23721722610
Net debt (negative = net cash)3−23−8−5−19−5−10

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: DARE vs LGVNLGVN vs STTKLGVN vs RNACLGVN vs MNOV

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Longeveron Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Longeveron Inc.